The Neuromodulation Podcast – Details, episodes & analysis

On today's minisode, Dr. Feroz Osmani reflects on his experience in interventional pain medicine at UChicago Medicine. He discusses the importance of patient selection for effective neuromodulation therapies, how patients can access optimal results, and the benefits of spinal cord stimulation for chronic pain.

He also draws upon an example from his personal life that illustrates the direct impact of neuromodulation therapies for pain management and provides practical advice for new fellows.

In this episode, Professor Konstantin Slavin reads aloud an article by Garston Liang, Alexander Thorpe, and Quentin F. Gronau, which delves into the Fragility Index (FI) and its significance in evaluating the robustness of p-value-based conclusions in clinical trials.

Key points include:

• Fragility Index (FI): Measures how many participant outcomes need to change to alter the statistical significance of results (e.g., from p < 0.05 to p > 0.05).
• Higher FI is Better: A higher FI indicates more robust conclusions, less dependent on a small number of participant changes.
• Key Considerations: Includes the alpha criterion (e.g., p < 0.05), what counts as a clinical event, and the overall sample size.

The article also addresses the importance of understanding the fragility of study results and provide insights into how FI can be used to assess the reliability of clinical trial outcomes.

Tune in to learn more about the Fragility Index and its application in medical research.

Resources:

1. Biostatistics articles on the INS website
2. The Fragility Index article

Dr. Lisa Goodman, assistant professor and FWO postdoctoral researcher, discusses the importance of statistics in the medical field. Statistics is important in every facet of medicine, from evaluating the safety of new therapies to comparing treatment options in clinical trials.

We explore the role of statistics in evidence-based medicine and precision medicine and offer guidance for clinicians to improve their understanding of statistical data to help make informed decisions and develop prediction models for personalized patient care.

Dr. Heather Pinckard-Dover, a neurosurgeon specializing in neuromodulation, shares her personal journey and passion for the field, offering insight for clinicians considering neuromodulation for their career path. She discusses the immediate impact and rewards of neuromodulation in improving patients' lives while also highlighting challenges such as U.S. insurance coverage and the importance of patient selection.

Neuromodulation is the interface between the nervous system and technology, and this episode explores how it can be used to treat a wide range of conditions and how patients can benefit. From awareness and accessibility to common misconceptions and his hope for the future of the field, this episode features Professor Lawrence Poree, MD, PhD, MPH, who addresses the importance of raising awareness about neuromodulation, as it is not widely taught in medical schools, which leads to a lack of awareness among both patients and physicians.

Welcome to The Neuromodulation Podcast, presented to you by the International Neuromodulation Society. Dive into the forefront of today’s emerging neuromodulation techniques, insights, and ethical and clinical applications. Subscribe now to join the multidisciplinary collaboration of medical care providers, scientists, and engineers who are part of the global conversation that’s shaping the future of healthcare.

In this episode, Professor Konstantin Slavin reads aloud an article by Garston Liang, Quentin F. Gronau, and Alexander Thorpe which discusses the p-value, a fundamental concept in statistical analysis, and clarify what it can and cannot tell you about your data. Key points include:

• What a p-value tells you: The probability that a null hypothesis generated the observed data.
• What a p-value cannot tell you: The effect size, the quality of alternative hypotheses, the presence of an effect, details of the sampling plan, or data pre-processing steps.

The hosts explore the limitations of p-values, emphasizing the importance of understanding their context and proper usage in scientific research. Tune in to gain a deeper insight into the role of p-values in hypothesis testing and avoid common misconceptions.

Resources:

1. Biostatistics articles on the INS website
2. What a P-value can and cannot tell you article

In this episode, Professor Konstantin Slavin reads aloud an article by Alexander Thorpe, Garston Liang, and Quentin F. Gronau which addresses Receiver Operating Characteristic (ROC) curves and the Area Under the Curve (AUC) in evaluating predictive models.

ROC curves help determine how well a model differentiates between two outcomes, and AUC measures model performance.

Key points covered include:

• ROC Curves: Assess model sensitivity and specificity over a range of thresholds.
• AUC: A higher AUC indicates better model performance, with values between 0.5 (chance level) and 1 (perfect performance).
• Interpreting AUC: While higher is better, what counts as a "good" AUC depends on the context.

Join us to learn how ROC curves and AUC can enhance your understanding of model effectiveness and help make more informed predictions in various fields.

Resources:

1. Biostatistics articles on the INS website

2. Receiver Operating Characteristics & the Area Under the Curve article

In this episode, Professor Konstantin Slavin reads aloud an article by Alexander Thorpe, Quentin F. Gronau, and Garston Liang which explores the various types of data and the appropriate statistical tests for each. Understanding data types is crucial for designing studies and analyzing data accurately. Key points include: - Data Categories: Data is broadly categorized into numerical (quantitative) and categorical (qualitative) types. - Numerical Data: Includes discrete, continuous, and ratio data. Common in quantitative research for measuring outcomes. - Categorical Data: Divided into ordinal (with inherent order) and nominal (without order) data. Examples include age groups (ordinal) and sex (nominal). The article also provide guidance on selecting the right statistical tests based on the combination of data types, helping listeners make informed decisions in their research and data analysis. Tune in to enhance your understanding of data classification and the corresponding statistical methods, ensuring accurate and meaningful research results.

Resources:

1. Biostatistics articles on the INS website
2. Types of Data and the Appropriate Tests for them article

In this episode, Prof. Konstantin Slavin reads aloud an article by Garston Liang, Quentin F. Gronau, and Alexander Thorpe which addresses the use of N-of-1 trials in neuromodulation and personalized medicine. N-of-1 trials are a powerful method for investigating treatment effects on an individual basis, making them ideal for patients with stable symptoms and chronic disorders.Key points covered include:- N-of-1 Trial Design: Involves repeated cycles of treatment and placebo, with the patient serving as their own control.- Personalization: Tailors treatment decisions to individual outcomes, offering a high level of evidence for treatment efficacy.- Double-Blinding: Ensures both patient and clinician are unaware of the treatment phase to maintain objectivity.- Crossover Design: Alternates between treatment and placebo phases, often randomized to prevent time-related biases.- Wash-In/Out Periods: Important for avoiding carry-over effects, especially in pharmaceutical interventions.The article also highlights the statistical considerations for analyzing N-of-1 trials, emphasizing the importance of proper design and analysis to ensure valid conclusions. Tune in to learn how N-of-1 trials can enhance personalized treatment strategies in neuromodulation and beyond.

Resources:

1. Biostatistics articles on the INS website
2. N-of-1 Trials & Their Use in Neuromodulation